Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

Completed · Phase 2 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

B1621007 is designed to study the safety and efficacy of PF-04937319 in patients with type 2 diabetes

Key facts

Study ID
NCT01475461
Run by
Pfizer
People needed
345
Starts
2011-11-01
Expected to finish
2013-01-01
Last updated by the study team
2017-01-31

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.